Good health is positively or negatively influenced by dietary habits & choices. In the current scenario, healthy fibre-rich plant-based food choices are replaced by high-fat sugary, animal fat-loaded & salty food cravings. Cumulatively this ongoing lifestyle disbalance is inviting life-threatening non-communicable diseases like obesity, type 2 diabetes mellitus, cardiovascular diseases & cancer.
Maintaining ideal body weight & losing extra weight is gaining popularity among the health-conscious population. Sugar consumption plays an important role in every weight-related journey. Sugar appetite is getting replaced by artificial sweeteners (AS).
The efficacy, safety & advantages of AS are not fully established & controversial. This needs a clear understanding of whether a high intake of AS is harmful or useful for diabetics.
The distinct structure of AS makes their metabolism, digestion & fermentation different. This has raised concerns towards the unmetabolized compounds in non-communicable disease development.
Acesulfame Potassium
Shows fast absorption, does not reach the low gastrointestinal tract & not impact intestinal microbiota. Mainly excreted through urine & faeces.
Saccharin
Partially excreted through urine & faeces. Small parts do not get absorbed immediately & affect intestinal microbiota.
Aspartame
Rapidly digested & not affecting intestinal microbiota.
Sucralose
Maximum part eliminated through faeces & urine. Affects gut microbiota through bacteriostatic effects.
Steviol Glycoside
Depicts slow metabolization & excretion through urine.
Body weight & adiposity
Energy balance gets affected by AS, thus the body weight. This process is different from natural sugar metabolism which acts through physiological processes comprising the gut microbiota, the reward system and adipogenesis.
AS interacts with the taste 1 receptor (T1R) family of sweet-taste receptors in the oral cavity and gastrointestinal tract, leading to changes in satiety, energy intake, adipogenesis & body weight. Simultaneously AS causes variation in intestinal bacterial balance by increasing short-chain fatty acid (SCFA) production. This brings enhancement in lipid oxidation, energy expenditure & disturbance in gut-brain signalling.
Gut microbiota
AS increases intestinal dysbiosis & changes the microbial composition and Bacteroidetes ratio.
Glucose homeostasis
After AS intake SGLT1 (sodium-glucose transporter 1) and GLUT2 (glucose transporter 2) get upregulated leading to an increase in intestinal glucose absorption. Also AS interacts with GPCR (G-protein coupled receptor) & affects insulin secretory capacity. AS-induced intestinal dysbiosis provokes SCFA production & affects insulin secretion. Concurrently LPS (lipopolysaccharide) levels increase, chronic inflammation & endotoxemia occur, fat accumulates & insulin resistance-mediated diabetes is established.
For healthy outcomes and good quality of life, adequate nutrition & positive lifestyle habits are required & not unnecessarily AS ingestion. Uncontrolled intake of AS & processed food made out of it is a threat to good health with an increased risk of chronic lifestyle diseases.
High AS usage is not a remedy to control diabetes but may alter insulin sensitivity & enhance proneness towards diabetes. AS usage should be minimized & future research is essential to understand the evidence about the safety & true benefits of AS in diabetes.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation